Cargando…

Enhanced and Extended Anti-Hypertensive Effect of VP5 Nanoparticles

Hypertension has become a significant global public health concern and is also one of the most common risk factors of cardiovascular disease. Recent studies have shown the promising result of peptides inhibiting angiotensin converting enzyme (ACE) in lowering the blood pressure in both animal models...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Ting, Zhao, Shengnan, Li, Ziqiang, Wang, Yi, Xu, Bei, Fang, Dailong, Wang, Fazhan, Zhang, Zhi, He, Lili, Song, Xiangrong, Yang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187777/ https://www.ncbi.nlm.nih.gov/pubmed/27898022 http://dx.doi.org/10.3390/ijms17121977

Ejemplares similares

Macrophage Foam Cell-Targeting Immunization Attenuates Atherosclerosis
por: Wang, Fazhan, et al.
Publicado: (2019)

Codon Optimization, Expression in Escherichia coli, and Immunogenicity of Recombinant Chinese Sacbrood Virus (CSBV) Structural Proteins VP1, VP2, and VP3
por: Fei, Dongliang, et al.
Publicado: (2015)

Fused IgY Fc and Polysaccharide Adjuvant Enhanced the Immune Effect of the Recombinant VP2 and VP5 Subunits—A Prospect for Improvement of Infectious Bursal Disease Virus Subunit Vaccine
por: Wang, Huining, et al.
Publicado: (2017)

Correction: Codon Optimization, Expression in Escherichia coli, and Immunogenicity of Recombinant Chinese Sacbrood Virus (CSBV) Structural Proteins VP1, VP2, and VP3
por: Fei, Dongliang, et al.
Publicado: (2015)

Molecular Characterization of Outer Capsid Proteins VP5 and VP7 of Grass Carp Reovirus
por: Zhang, Fuxian, et al.
Publicado: (2022)

Infectious pancreatic necrosis virus proteins VP2, VP3, VP4 and VP5 antagonize IFNa1 promoter activation while VP1 induces IFNa1
por: Lauksund, Silje, et al.
Publicado: (2015)

Avibirnavirus VP4 Protein Is a Phosphoprotein and Partially Contributes to the Cleavage of Intermediate Precursor VP4-VP3 Polyprotein
por: Wang, Sanying, et al.
Publicado: (2015)

The rotavirus VP5*/VP8* conformational transition permeabilizes membranes to Ca(2+)
por: De Sautu, Marilina, et al.
Publicado: (2023)

Molecular evolution of the VP1, VP2, and VP3 genes in human rhinovirus species C
por: Kuroda, Makoto, et al.
Publicado: (2015)

Development of Monoclonal Antibody to Specifically Recognize VP0 but Not VP4 and VP2 of Foot-and-Mouth Disease Virus
por: Park, Sun Young, et al.
Publicado: (2022)

The Functional Characterization of Bat and Human P[3] Rotavirus VP8*s
por: Li, Dandi, et al.
Publicado: (2021)

Analysis of Conserved, Computationally Predicted Epitope Regions for VP5 and VP7 Across three Orbiviruses
por: Russell, Bonnie L, et al.
Publicado: (2018)

Comparing Enterovirus 71 with Coxsackievirus A16 by analyzing nucleotide sequences and antigenicity of recombinant proteins of VP1s and VP4s
por: Li, Yuyun, et al.
Publicado: (2011)

Genetic Characterizations and Molecular Evolution of VP7 Gene in Human Group A Rotavirus G1
por: Zhou, Nan, et al.
Publicado: (2020)

Structural Insights into the Cytotoxic Mechanism of Vibrio parahaemolyticus PirA(vp) and PirB(vp) Toxins
por: Lin, Shin-Jen, et al.
Publicado: (2017)

Phylogenetic analysis of the viral proteins VP4/VP7 of circulating human rotavirus strains in China from 2016 to 2019 and comparison of their antigenic epitopes with those of vaccine strains
por: Mao, Tongyao, et al.
Publicado: (2022)

Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effect
por: Amarachinta, Padmanabha Rao, et al.
Publicado: (2021)

Extended Application of Genomic Selection to Screen Multi-Omics Data for the Development of Novel Pyroptosis-Immune Signatures and Predicting Immunotherapy of Glioma
por: Ma, Shuai, et al.
Publicado: (2022)

Antigenicity and Immunogenicity Analysis of the E. coli Expressed FMDV Structural Proteins; VP1, VP0, VP3 of the South African Territories Type 2 Virus
por: Li, Guoxiu, et al.
Publicado: (2021)

Anti-VP6 VHH: An Experimental Treatment for Rotavirus A-Associated Disease
por: Maffey, Lucía, et al.
Publicado: (2016)

Expression of the AHPND Toxins PirA(vp) and PirB(vp) Is Regulated by Components of the Vibrio parahaemolyticus Quorum Sensing (QS) System
por: Lin, Shin-Jen, et al.
Publicado: (2022)

Progressive multifocal leukoencephalopathy and granule cell neuronopathy with novel mutation flanking VP1 C-terminus in natalizumab-extended interval dosing
por: Rempe, Torge, et al.
Publicado: (2020)

Strain-Specific Interactions between the Viral Capsid Proteins VP4, VP7 and VP6 Influence Rescue of Rotavirus Reassortants by Reverse Genetics
por: Valusenko-Mehrkens, Roman, et al.
Publicado: (2023)

VP4/VP56/VP35 Virus-like Particles Effectively Protect Grass Carp (Ctenopharyngodon idella) against GCRV-II Infection
por: Tian, Qingqing, et al.
Publicado: (2023)

Optimization of the Linker Length of Mannose-Cholesterol Conjugates for Enhanced mRNA Delivery to Dendritic Cells by Liposomes
por: Wang, Fazhan, et al.
Publicado: (2018)

Correction to: Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effect
por: Amarachinta, Padmanabha Rao, et al.
Publicado: (2021)

VP Simulation and Track Reconstruction
por: Bird, T, et al.
Publicado: (2013)

Structural Insights to the Heterotetrameric Interaction between the Vibrio parahaemolyticus PirA(vp) and PirB(vp) Toxins and Activation of the Cry-Like Pore-Forming Domain
por: Lin, Shin-Jen, et al.
Publicado: (2019)

Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology
por: Johnson, Reed F, et al.
Publicado: (2006)

Classification of group A rotavirus VP7 and VP4 genotypes using random forest
por: Tran, Hoc, et al.
Publicado: (2023)

Enhanced effect of microdystrophin gene transfection by HSV-VP22 mediated intercellular protein transport
por: Xiong, Fu, et al.
Publicado: (2007)

A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity
por: Dong, Hu, et al.
Publicado: (2021)

Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax
por: Perkins, Stuart D, et al.
Publicado: (2005)

The epitope of the VP1 protein of porcine parvovirus
por: Xie, Hong-ling, et al.
Publicado: (2010)

A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses
por: Xia, Ming, et al.
Publicado: (2021)

Solid lipid nanoparticles as an effective sodium aescinate delivery system: formulation and anti-inflammatory activity
por: Wang, Jinyue, et al.
Publicado: (2022)

Functional Comparison between VP64-dCas9-VP64 and dCas9-VP192 CRISPR Activators in Human Embryonic Kidney Cells
por: Javaid, Nasir, et al.
Publicado: (2021)

Serological detection and analysis of anti-VP1 responses against various enteroviruses (EV) (EV-A, EV-B and EV-C) in Chinese individuals
por: Gao, Caixia, et al.
Publicado: (2016)

Localization studies of two white spot syndrome virus structural proteins VP51 and VP76
por: Wu, Chenglin, et al.
Publicado: (2006)

Ubiquitin Ligase SMURF2 Interacts with Filovirus VP40 and Promotes Egress of VP40 VLPs
por: Shepley-McTaggart, Ariel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8cpkf088bpcq4cuktg8sobhasu